-
-
-
De Boer AR, et al. Hart- en vaatziekten in Nederland 2018, cijfers over risicofactoren, hartinterventies, ziekte en sterfte. Den Haag: Hartstichting, 2018.
-
Sarwar N, Gao P, Kondapally Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22.
-
Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018; 17(1):83.
-
Nichols G, Gullion CM, Koro CE, et al. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004; 27(8):1879-84.
-
Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-70.
-
Harmel AP, et al. Davidson’s Diabetes Mellitus: Diagnosis and Treatment. 5th ed. Philadelphia, PA: Saunders. 2004.
-
DeFronzo RA. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773-95.
-
Hirsch N. Insulin analogues. Engl J Med. 2005; 352:174-83.
-
-
-
-
-
Flood TM. Appropriate use of insulin analogs in an increasingly complex type 2 diabetes mellitus (T2DM) landscape. J Fam Pract. 2007; 56(1 Suppl):S1-S10.
-
Becker RHA, Dahmen R, Bergmann K, et al. New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1. Diabetes Care. 2015; 38(4):637-43.
-
Heise T, Jordan J, Wanner C, et al. Pharmacodynamic effects of single and multiple doses of empagliflozin in patients with type 2 diabetes. Clin Ther. 2016; 38(10):2265-2276.
-
Vallon V, Thomson SC. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia. 2017; 60(2):215-225.
-
Bakris GL, Fonseca VA, Sharma K, et al. Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications Kidney Int. 2009; 75(12):1272-1277.
-
-
Persson F, Borg R, Rossing P. A narrative review of new treatment options for chronic kidney disease in type 2 diabetes. Ann Transl Med. 2021; 9(8):716.
-
-
-
-
Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(2):137-155.
Account
1
